Literature DB >> 32377260

Preclinical Voxel-Based Dosimetry in Theranostics: a Review.

Arun Gupta1, Min Sun Lee2, Joong Hyun Kim3, Dong Soo Lee4, Jae Sung Lee4,5,6.   

Abstract

Due to the increasing use of preclinical targeted radionuclide therapy (TRT) studies for the development of novel theranostic agents, several studies have been performed to accurately estimate absorbed doses to mice at the voxel level using reference mouse phantoms and Monte Carlo (MC) simulations. Accurate dosimetry is important in preclinical theranostics to interpret radiobiological dose-response relationships and to translate results for clinical use. Direct MC (DMC) simulation is believed to produce more realistic voxel-level dose distribution with high precision because tissue heterogeneities and nonuniform source distributions in patients or animals are considered. Although MC simulation is considered to be an accurate method for voxel-based absorbed dose calculations, it is time-consuming, computationally demanding, and often impractical in daily practice. In this review, we focus on the current status of voxel-based dosimetry methods applied in preclinical theranostics and discuss the need for accurate and fast voxel-based dosimetry methods for pretherapy absorbed dose calculations to optimize the dose computation time in preclinical TRT. © Korean Society of Nuclear Medicine 2020.

Entities:  

Keywords:  177Lu; Monte Carlo; Preclinical; Theranostic; Voxel-based dosimetry

Year:  2020        PMID: 32377260      PMCID: PMC7198676          DOI: 10.1007/s13139-020-00640-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  119 in total

Review 1.  The impact of PET and SPECT on dosimetry for targeted radionuclide therapy.

Authors:  Glenn Flux; Manuel Bardies; Myriam Monsieurs; Sauli Savolainen; Sven-Erik Strands; Michael Lassmann
Journal:  Z Med Phys       Date:  2006       Impact factor: 4.820

Review 2.  Small-animal SPECT and SPECT/CT: important tools for preclinical investigation.

Authors:  Benjamin L Franc; Paul D Acton; Carina Mari; Bruce H Hasegawa
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

3.  GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy.

Authors:  S Jan; D Benoit; E Becheva; T Carlier; F Cassol; P Descourt; T Frisson; L Grevillot; L Guigues; L Maigne; C Morel; Y Perrot; N Rehfeld; D Sarrut; D R Schaart; S Stute; U Pietrzyk; D Visvikis; N Zahra; I Buvat
Journal:  Phys Med Biol       Date:  2011-01-20       Impact factor: 3.609

4.  The Future of Radioligand Therapy: α, β, or Both?

Authors:  Uwe Haberkorn; Frederik Giesel; Alfred Morgenstern; Clemens Kratochwil
Journal:  J Nucl Med       Date:  2017-04-13       Impact factor: 10.057

5.  A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor.

Authors:  A A Flynn; A J Green; R B Pedley; G M Boxer; R Boden; R H Begent
Journal:  Radiat Res       Date:  2001-07       Impact factor: 2.841

6.  [177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.

Authors:  M de Jong; W A Breeman; B F Bernard; W H Bakker; M Schaar; A van Gameren; J E Bugaj; J Erion; M Schmidt; A Srinivasan; E P Krenning
Journal:  Int J Cancer       Date:  2001-06-01       Impact factor: 7.396

Review 7.  Therapeutic radionuclides: biophysical and radiobiologic principles.

Authors:  Amin I Kassis
Journal:  Semin Nucl Med       Date:  2008-09       Impact factor: 4.446

8.  68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents.

Authors:  Jothilingam Sivapackiam; Richard Laforest; Vijay Sharma
Journal:  Nucl Med Biol       Date:  2017-12-01       Impact factor: 2.408

9.  A mouse bone marrow dosimetry model.

Authors:  M S Muthuswamy; P L Roberson; D J Buchsbaum
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

10.  Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies.

Authors:  Ciara M Finucane; Iain Murray; Jane K Sosabowski; Julie M Foster; Stephen J Mather
Journal:  Int J Mol Imaging       Date:  2011-03-16
View more
  1 in total

Review 1.  Individualization of Radionuclide Therapies: Challenges and Prospects.

Authors:  Hanna Piwowarska-Bilska; Sara Kurkowska; Bozena Birkenfeld
Journal:  Cancers (Basel)       Date:  2022-07-14       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.